Main contents of the meetings of the two sessions of the National People's Congress in 2021
(1) Agenda of the Fourth Session of the 13th National People's Congress
1.Consideration of the report on the work of the government
2.Examination of the draft outlines of the 14th Five-Year Plan for National Economic and Social Development and the 2035 Vision
3.Examination of the report on the implementation of the National Economic and Social Development Plan for 2020 and the draft of the 2021 Plan for National Economic and Social Development
3? Report on the Implementation of the National Economic and Social Development Plan for 2020 and the Draft National Economic and Social Development Plan for 2021, and the Draft National Economic and Social Development Plan for 2021
4?Examine the Report on the Implementation of the Central and Local Budgets for 2020 and the Draft Central and Local Budgets for 2021, and the Draft Central and Local Budgets for 2021
5.Consideration of the Report by the Standing Committee of the National People's Congress Consideration of the motion of the Standing Committee of the National People's Congress on submitting for consideration the Draft Amendment to the Organic Law of the National People's Congress of the People's Republic of China
6?Consideration of the motion of the Standing Committee of the National People's Congress on submitting for consideration the Draft Amendment to the Rules of Procedure of the National People's Congress of the People's Republic of China
7?Consideration of the report on the work of the Standing Committee of the National People's Congress
8?Consideration of the report on the work of the Supreme People's Court
9?Consideration of the report on the work of the Supreme People's Procuratorate
(2)Agenda of the Fourth Session of the 13th National Committee of the Chinese People's Political Consultative Conference (CPPCC)
1.To listen to and deliberate on the report on the work of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference (CPPCC)
2.To listen to and deliberate on the report on the work of the CPPCC's National Committee in regard to the work of making proposals
3. Attend the Fourth Session of the Thirteenth National People's Congress to listen to and discuss the report on the work of the government and other relevant reports
4. Consider and adopt the political resolution of the Fourth Session of the Thirteenth National Committee of the Chinese People's Political Consultative Conference (CPPCC)
5. Consider and adopt the resolution on the report on the work of the Standing Committee of the Thirteenth National Committee of the CPPCC at its Fourth Session
Note:The schedule is subject to change with official notification.
Four, what is the impact of the two sessions on the stock market?
The market entered the two sessions time. Policy tone, epidemic prevention and control, economic data, development goals, people's livelihood and other hot issues have become the focus of global attention. At the same time, the stock market has officially entered the two sessions time. Next we analyze the stock market sentiment of the two sessions of the previous years, as well as the impact of this year's National People's Congress on the analysis of the broader market.
From the historical data, the stock market shows a certain ? The effect of the two sessions? Securities Times? Data treasure statistics, in the past ten years (2010~2019), the SSE index rose six times during the two sessions***, and all the SSE indexes made positive returns during the two sessions in the past five years. After the end of the two sessions of the general market uptrend is still a short-term continuation of the introduction of relevant policies to form a favorable after the meeting continued to ferment. At the end of the two sessions of 5 days and 10 days, the probability of the market rose to 60% and 70% respectively, and the rate of increase is expanding.
GEM's performance during the two sessions was even better, with a winning rate of two-thirds. Nearly ten years during the two sessions of the GEM index rose an average of 1.51%, better than the performance of the SSE index during the same period. 2019 and 2018 during the two sessions of the GEM index rose even more as high as 6.04% and 5.23%, respectively, on the whole, the two sessions of the release of positive signals on the stock market trend to play a positive catalytic effect.
Food and beverage industry during the two sessions of the winning rate of 80%
The trend of the two sessions of the industry diverged, most of the industry performance is relatively flat. Data treasure statistics, in the past ten years, 28 Shenwan level industry only food and beverage and and communications industry during the two sessions of the winning rate of more than 50%, respectively, 80% and 60%, food and beverage industry is the absolute winner. Extractive, non-ferrous metals, transportation and other five industries have a winning rate of only 30%.
Index gains and losses to see, the past ten years during the two sessions of only 11 industry index average gain of more than 0, of which, pharmaceutical and biological index average gain was the highest, amounting to 1.41%, food and beverage industry average gain of 1.34%, ranked second. Iron and steel, extractive, defense industry, non-banking financial performance is the worst, the average decline of more than 1.3%.
CBIC predicts the government will continue to broadly support domestic demand and consumption, while targeting infrastructure investment and employment. Data from previous years show that consumer stocks mostly outperform the market around the two sessions. Considering this year's policy support as well as external risks, consumer stocks (including retail, restaurants, automobiles, education and e-commerce) are expected to continue to benefit from the two sessions and become winners this year.
In addition, infrastructure investment will remain an important support for economic growth, and the government is expected to approve more infrastructure projects after the two sessions. CBI expects demand for construction machinery and heavy trucks to continue to rise in the second half of this year. Relevant targets include Sany Heavy Industry, Hengli Hydraulic, Weichai Power, Zhejiang Dingli and so on.
The pharmaceutical sector is also a major focus of attention under the impact of the new Crown pneumonia epidemic. Huaxi Securities believes that the theme of medicine has three major investment lines of concern:
One is the construction of medical facilities: the epidemic to promote medical facilities to make up for the future of the new infrastructure under the procurement of medical equipment, to promote the construction of medical facilities. The demand for some specific medical equipment after the epidemic is bound to increase dramatically. In the China Medical Equipment Association issued a new crown pneumonia epidemic prevention and control of urgently needed medical equipment catalog, involving 18 listed companies, including Wanfu biological, Myriad Medical, Ribbon Instruments, Wandong Medical, Yuyue Medical and so on.
The second is the vaccine: the new crown epidemic to enhance the vaccine knowledge rate, the vaccine long-term vaccination rate will continue to improve. From the point of view of investment in the vaccine industry and the future market space of heavy varieties, the product pipeline is becoming more and more important to the company, especially the heavy non-immunization planning vaccines with significant improvements and exclusive advantages.
Related segments of the A-share listed companies include: Zhifei Biological (Mycobacterium bovis vaccine, AC-Hib triple vaccine, diploid rabies vaccine, 15-valent pneumonia conjugate vaccine, tetravalent norovirus vaccine, etc.), Contagious Biological (13-valent pneumonia conjugate vaccine, diploid rabies vaccine, quadruple vaccine & quintuplicate vaccine, pentavalent rotavirus vaccine, etc.), Hualan Biological (4-valent influenza vaccine , rabies vaccine, AC conjugate vaccine, etc.), Changchun High-Tech (nasal spray influenza vaccine, rabies vaccine, herpes zoster vaccine, varicella vaccine, etc.), Watson Biologicals (13-valent pneumococcal conjugate vaccine, 2-valent HPV vaccine, etc.) and so on.
Third, innovative drugs: the importance of innovative drug research and development under the epidemic has become more apparent. Innovative drugs and biopharmaceuticals in the field of standard: Hengrui Pharmaceuticals, China Biopharmaceuticals, Henson Pharmaceuticals, Shiyi Group, Beida Pharmaceuticals, Hesco, Keren Pharmaceuticals, Fosun Pharmaceuticals, Kanghong Pharmaceuticals, Tonghua Dongbao; CXO (pharmaceutical outsourcing) in the field of standard: WuXi Kande, Boten shares, Taiga Pharmaceuticals, Zhaoyan New Drugs, etc.
Three is the innovative drug: under the epidemic the importance of research and development has become more apparent.